Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International Inc commences exchange offer for Allergan Inc


Wednesday, 18 Jun 2014 09:30am EDT 

Allergan Inc:Says Valeant Pharmaceuticals International Inc announced that it has commenced an exchange offer for common stock of Allergan Inc.Under terms of offer, Allergan stockholders would be able to elect to exchange each of their Allergan shares for $72.00 in cash and 0.83 Valeant common shares, or an amount of cash, or number of Valeant common shares, in each case subject to proration.Valeant says amount of all cash and all stock elections would be determined prior to expiration of exchange offer.Offer is scheduled to expire at New York City time, on Aug. 15, 2014, unless offer is extended.Valeant expects to complete second-step merger promptly following consummation of exchange offer in order to acquire the remaining Allergan shares. 

Company Quote

183.45
0.64 +0.35%
3:47pm EDT